Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 18, 2011 - Issue 4
195
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis

, , , , , , , , , , , , & show all
Pages 216-221 | Received 17 Sep 2011, Accepted 22 Sep 2011, Published online: 09 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Natalia Kreiniz & Morie A. Gertz. (2023) Bad players in AL amyloidosis in the current era of treatment. Expert Review of Hematology 16:1, pages 33-49.
Read now
Marco Basset, Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. (2020) Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside. Expert Review of Hematology 13:9, pages 1003-1015.
Read now
Paolo Milani, Giovanni Palladini & Giampaolo Merlini. (2018) New concepts in the treatment and diagnosis of amyloidosis. Expert Review of Hematology 11:2, pages 117-127.
Read now

Articles from other publishers (21)

Eugene S J Tan, Yen Yee Oon, Siew Pang Chan, Oi Wah Liew, Jenny P C Chong, Edgar Tay, Wern Miin Soo, James W L Yip, Lingli Gong, Josephine B Lunaria, Quek Wei Yong, Evelyn Min Lee, Daniel P S Yeo, Zee Pin Ding, Hak Chiaw Tang, See Hooi Ewe, Calvin C W Chin, Siang Chew Chai, Ping Ping Goh, Lee Fong Ling, Hean Yee Ong, A Mark Richards & Lieng Hsi Ling. (2022) Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis. Heart 108:16, pages 1319-1327.
Crossref
Federico Perfetto, Mattia Zampieri, Carlo Fumagalli, Marco Allinovi & Francesco Cappelli. (2022) Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist. Internal and Emergency Medicine 17:4, pages 957-969.
Crossref
Vincenzo Castiglione, Maria Franzini, Alberto Aimo, Alessandro Carecci, Carlo Mario Lombardi, Claudio Passino, Claudio Rapezzi, Michele Emdin & Giuseppe Vergaro. (2021) Use of biomarkers to diagnose and manage cardiac amyloidosis. European Journal of Heart Failure 23:2, pages 217-230.
Crossref
Arianna Pregenzer-Wenzler, Jo Abraham, Kelsey Barrell, Tibor Kovacsovics & Jose Nativi-Nicolau. (2020) Utility of Biomarkers in Cardiac Amyloidosis. JACC: Heart Failure 8:9, pages 701-711.
Crossref
Oliver C. Cohen & Ashutosh D. Wechalekar. (2020) Systemic amyloidosis: moving into the spotlight. Leukemia 34:5, pages 1215-1228.
Crossref
Assuero Giorgetti, Dario Genovesi & Michele Emdin. (2018) Cardiac amyloidosis: The starched heart. Journal of Nuclear Cardiology 27:1, pages 133-136.
Crossref
Assuero Giorgetti, Dario Genovesi, Elisa Milan, Wanda Acampa, Raffaele Giubbini, Alberto Cuocolo & Paolo Marzullo. (2019) Cardiac amyloidosis. Clinical and Translational Imaging 7:1, pages 21-32.
Crossref
Marco Luciani, Luca Troncone & Federica Del Monte. (2018) Current and future circulating biomarkers for cardiac amyloidosis. Acta Pharmacologica Sinica 39:7, pages 1133-1141.
Crossref
Martha Grogan, Angela Dispenzieri & Morie A Gertz. (2017) Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart 103:14, pages 1065-1072.
Crossref
Stefano Perlini, Roberta Mussinelli & Francesco Salinaro. (2016) New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis. Current Heart Failure Reports 13:6, pages 267-272.
Crossref
G Merlini, I Lousada, Y Ando, A Dispenzieri, M A Gertz, M Grogan, M S Maurer, V Sanchorawala, A Wechalekar, G Palladini & R L Comenzo. (2016) Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia 30:10, pages 1979-1986.
Crossref
Mario Nuvolone & Giampaolo Merlini. (2016) Systemic amyloidosis: novel therapies and role of biomarkers. Nephrology Dialysis Transplantation, pages gfw305.
Crossref
Giuseppe Lippi, Federico Schena, Gian Luca Salvagno, Fabian Sanchis-Gomar & Gian Cesare Guidi. (2015) Serum Copeptin and Midregion Proadrenomedullin (MR-proADM) After an Ultramarathon. Journal of Clinical Laboratory Analysis 29:1, pages 15-20.
Crossref
Brendan M. WeissJoseph HebreoDaniel V. CordaroMark J. RoschewskiThomas P. BakerKevin C. AbbottStephen W. Olson. (2014) Increased Serum Free Light Chains Precede the Presentation of Immunoglobulin Light Chain Amyloidosis. Journal of Clinical Oncology 32:25, pages 2699-2704.
Crossref
Francesca Lavatelli, Riccardo Albertini, Andrea Di Fonzo, Giovanni Palladini & Giampaolo Merlini. (2014) Biochemical markers in early diagnosis and management of systemic amyloidoses. Clinical Chemistry and Laboratory Medicine (CCLM) 52:11.
Crossref
Giovanni Palladini & Giampaolo Merlini. (2013) Systemic amyloidoses: What an internist should know. European Journal of Internal Medicine 24:8, pages 729-739.
Crossref
Dania Mohty, Thibaud Damy, Pierre Cosnay, Najmeddine Echahidi, Danielle Casset-Senon, Patrice Virot & Arnaud Jaccard. (2013) Cardiac amyloidosis: Updates in diagnosis and management. Archives of Cardiovascular Diseases 106:10, pages 528-540.
Crossref
Fabian Sanchis-Gomar, Chiara Bonaguri, Rosalia Aloe, Helios Pareja-Galeano, Vladimir Martinez-Bello, Mari Carmen Gomez-Cabrera, Jorge Candel, Jose Viña & Giuseppe Lippi. (2013) Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers. Translational Research 162:2, pages 102-109.
Crossref
Deepa M. Gopal & Flora Sam. (2013) New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy. Journal of Cardiovascular Translational Research 6:4, pages 516-527.
Crossref
Bouke P.C. Hazenberg. (2013) Amyloidosis. Rheumatic Disease Clinics of North America 39:2, pages 323-345.
Crossref
Giovanni Palladini & Raymond L. Comenzo. 2012. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease 609 642 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.